“…Since their discovery, microRNAs have been suggested as potential biomarkers in many diseases, including neurological disorders such as Alzheimer's disease (Femminella et al, 2015;Dangla-Valls et al, 2016), Parkinson's disease (Hoss et al, 2016;Thome et al, 2016), Multiple Sclerosis (Jr Ode et al, 2013), and epilepsy (Wang et al, 2015a;Raoof et al, 2017). MicroRNAs are expressed in various body fluids including blood, cerebrospinal fluid (CSF), urine, ascetic fluid, amniotic fluid, and tears (Cortez et al, 2011), where they demonstrate remarkable stability.…”